- Associated Press - Wednesday, July 16, 2014

MADISON, Wis. (AP) - Wisconsin will receive $200,000 for its Medicaid program from the settlement of a multi-state lawsuit accusing a pharmaceutical company of improperly marketing a drug.

Wisconsin State Journal reported Wednesday (https://bit.ly/1qHae49 ) that Illinois-based Astellas Pharma US Inc. will pay a total of $7.3 million in the settlement with multiple states and the federal government.

The Wisconsin Attorney General’s Office says in a statement that the company promoted pediatric use of the drug Mycamine from 2005 to 2010, even though the Food and Drug Administration hadn’t approved it for children.

The anti-fungal agent is approved for use in adults with certain infections. It also can be used to prevent infections in adults undergoing stem cell transplants.

___

Information from: Wisconsin State Journal, https://www.madison.com/wsj

Copyright © 2018 The Washington Times, LLC.

The Washington Times Comment Policy

The Washington Times is switching its third-party commenting system from Disqus to Spot.IM. You will need to either create an account with Spot.im or if you wish to use your Disqus account look under the Conversation for the link "Have a Disqus Account?". Please read our Comment Policy before commenting.

 

Click to Read More

Click to Hide